Showing results (2051-2060 of 5,025) with videos related to
Sort By:
Pageof 503
World Journal of Urology|September 14, 2021
Late relapsing germ cell tumors with elevated tumor markersYue Che, Achim Lusch, Christian Winter, et al.Science (New York, N.Y.)|May 4, 1984
Vasopressin injected into the hypothalamus triggers a stereotypic behavior in golden hamstersC F Ferris, H E Albers, S M Wesolowski, et al.Journal of the American College of Cardiology|May 20, 1999
Three-dimensional color Doppler: a clinical study in patients with mitral regurgitationR De Simone, G Glombitza, C F Vahl, et al.Transgenic Research|January 21, 2017
A simple DNA recombination screening method by RT-PCR as an alternative to Southern blotEliene Albers, Mauro Sbroggiò, Javier Martin-Gonzalez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2003
Predictors of occult metastasis in clinical stage I nonseminoma: a systematic reviewYvonne Vergouwe, Ewout W Steyerberg, Marinus J C Eijkemans, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|April 1, 1995
LDL physical and chemical properties in familial combined hyperlipidemiaJ E Hokanson, R M Krauss, J J Albers, et al.Stroke|February 10, 2021
Clinical Outcomes and Identification of Patients With Persistent Penumbral Profiles Beyond 24 Hours From Last Known Well: Analysis From DEFUSE 3Amrou Sarraj, Michael Mlynash, Jeremy Heit, et al.Acta Biomaterialia|July 4, 2012
Inhibition of endogenous antagonists with an engineered BMP-2 variant increases BMP-2 efficacy in rat femoral defect healingHans-Jörg Sebald, Frank M Klenke, Mark Siegrist, et al.Urologic Oncology|September 5, 2012
Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancersGünter Niegisch, Judith Knievel, Annemarie Koch, et al.Neurology|July 23, 1998
Angiographically defined primary angiitis of the CNS: is it really benign?A R Woolfenden, D C Tong, M P Marks, et al.Pageof 503